Tenofovir Lamivudine and Efavirenz Tablet
Available Composition of
Name | Strength | Therapeutic use | View More |
---|---|---|---|
Lamivudine, Zidovudine and Nevirapine Tablet | 150 mg + 300 mg + 200 mg | AIDS, Anti Viral, Hepatitis Care, HIV Care | |
Lamivudine and Zidovudine Tablet | 150 mg + 300 mg | HIV Care | |
Lamivudine and Tenofovir Tablet | 300 mg + 300 mg | AIDS, hepatitis B virus (HBV) infection, HIV Care | |
Lamivudine and Stavudine Tablet | 150 mg + 30 mg | HIV Care, AIDS | |
Tenofovir Lamivudine and Efavirenz Tablet | 300 mg + 300 mg + 600 mg | HIV Care | |
Tenofovir Tablet | 300 mg | HIV Care, Hepatitis Care | |
Emtricitabine, Tenofovir and Efavirenz Tablet | 200 mg + 300 mg + 600 mg | Anti Viral, HIV Care | |
Emtricitabine and Tenofovir Tablet | 200 mg +300 mg | Anti Viral, HIV Care | |
Efavirenz Tablet / Capsule | 200 mg, 600 mg | Anti Viral, HIV Care | |
Abacavir and Lamivudine Tablet | 600 mg + 300 mg | HIV Care |
Product Description For Tenofovir Lamivudine and Efavirenz Tablet
products details and uses
Tenofovir Lamivudine and Efavirenz Tablet Exporter India, Manufacturer and Global Supplier
For effective HIV treatment, selecting a reliable Tenofovir, Lamivudine and Efavirenz Tablet Exporter India is essential. This fixed-dose combination tablet is widely prescribed for patients living with HIV-1 infection, helping to suppress viral replication and improve immune function. Manufactured under stringent quality standards, it ensures efficacy, safety, and patient compliance. As a leading Tenofovir, Lamivudine and Efavirenz Tablet Exporter India, we provide high-quality products for both domestic and international markets.
Uses of Tenofovir Lamivudine and Efavirenz Tablet
-
Effective treatment of HIV-1 infection in adults.
-
Reduces viral load and increases CD4 cell count to improve immune function.
-
Provides a convenient once-daily oral therapy for long-term HIV management.
-
Often used as part of combination therapy to prevent the development of drug resistance.
Being a trusted Tenofovir Lamivudine and Efavirenz Tablet Exporter India, we ensure that every batch meets international quality standards, making it safe and reliable for global distribution.
Precautions
Patients must follow certain precautions while using this combination tablet:
-
Avoid during pregnancy and breastfeeding unless specifically advised by a healthcare professional.
-
Use cautiously in patients with kidney or liver impairment.
-
Regular monitoring of renal function, liver function, and viral load is recommended.
-
Do not stop therapy abruptly without medical guidance.
-
Follow the prescribed dosage strictly to maximize therapeutic effect.
As a certified Tenofovir Lamivudine and Efavirenz Tablet Exporter India, we provide detailed instructions and safety guidelines to ensure patient safety and efficacy.
Possible Side Effects
Like all medications, this tablet may cause mild to moderate side effects in some patients:
-
Nausea or vomiting
-
Headache or dizziness
-
Fatigue
-
Abdominal discomfort
-
Rare allergic reactions or rash
Most side effects are temporary and manageable under medical supervision. As a trusted Tenofovir Lamivudine and Efavirenz Tablet Exporter India, we ensure that our products are safe, effective, and patient-friendly.
Why Choose Us?
-
WHO-GMP & ISO Certified Manufacturing Units – Ensuring international quality standards.
-
Reliable Exporter – Supplying Tenofovir, Lamivudine and Efavirenz Tablet to multiple countries worldwide.
-
Competitive Pricing – Affordable solutions without compromising quality.
-
Bulk Supply & Customized Packaging – Flexible solutions for distributors, hospitals, and pharmacies.
-
Regulatory Compliance – Products manufactured according to global guidelines.
-
Proven Track Record – Trusted Tenofovir Lamivudine and Efavirenz Tablet Exporter India delivering quality products with timely shipment.
Global Distribution Network
With a strong logistics and compliance framework, we successfully export to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.